Orally administered beta-glucan attenuates the Th2 response in a model of airway hypersensitivity
Authors
Burg, Ashley R.Quigley, Laura
Jones, Adam V.
O'Connor, Geraldine M.
Boelte, Kimberly
McVicar, Daniel W.
Orr, Selinda J.
Affiliation
National Cancer Institute-Frederick; University of Alabama at Birmingham; University Dental Hospital, Cardiff and Vale University Health Board; University of Chester; Cardiff University School of MedicinePublication Date
2016-06-21
Metadata
Show full item recordAbstract
beta-Glucan is a polysaccharide that can be extracted from fungal cell walls. Wellmune WGP((R)), a preparation of beta-1,3/1,6-glucans, is a dietary supplement that has immunomodulating properties. Here we investigated the effect WGP had on a mouse model of asthma. OVA-induced asthma in mice is characterized by infiltration of eosinophils into the lung, production of Th2 cytokines and IgE. Daily oral administration of WGP (400 microg) significantly reduced the influx of eosinophils into the lungs of OVA-challenged mice compared to control mice. In addition, WGP inhibited pulmonary production of Th2 cytokines (IL-4, IL-5, IL-13), however serum IgE levels were unaffected by WGP treatment. These data indicate that WGP could potentially be useful as an oral supplement for some asthma patients, however, it would need to be combined with therapies that target other aspects of the disease such as IgE levels. As such, further studies that examine the potential of WGP in combination with other therapies should be explored.Citation
Burg, A. R., Quigley, L., Jones, A. V., O'Connor, G. M., Boelte, K., McVicar, D. W., & Orr, S. J. (2016). Orally administered beta-glucan attenuates the Th2 response in a model of airway hypersensitivity. SpringerPlus, 5(1), 815. doi:10.1186/s40064-016-2501-1Publisher
SpringerJournal
SpringerPlusAdditional Links
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916077/http://link.springer.com/article/10.1186/s40064-016-2501-1/fulltext.html
Type
ArticleLanguage
enDescription
The final publication is available at Springer via http://dx.doi.org/10.1186/s40064-016-2501-1EISSN
2193-1801ae974a485f413a2113503eed53cd6c53
10.1186/s40064-016-2501-1
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/